@Davisite, I'm not sure if this has been asked and I've missed it, but are you able to elaborate on what we should expect from the toxicology studies?
For example, I assume the outcome is not "RC220 passes or (heaven forbid) fails" and therefore can/can't be used in clinical trials. I would also assume that we should expect the studies will show that RC220 is toxic, with the level of toxicity being dependent on the dose given.
But other than a delay, is there anything else that can go wrong with these studies? Is it possible to get a great / good / bad result for RC220 and if so what would those scenarios look like?
Thanks in advance.
- Forums
- General
- General Comments / Chat
@Davisite, I'm not sure if this has been asked and I've missed...
-
- There are more pages in this discussion • 582 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.62 |
Change
0.060(3.85%) |
Mkt cap ! $272.6M |
Open | High | Low | Value | Volume |
$1.57 | $1.62 | $1.57 | $105.4K | 65.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3336 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.63 | 136 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3854 | 1.600 |
4 | 10261 | 1.595 |
3 | 11950 | 1.590 |
1 | 24285 | 1.580 |
1 | 950 | 1.575 |
Price($) | Vol. | No. |
---|---|---|
1.620 | 8630 | 3 |
1.625 | 201 | 1 |
1.630 | 20380 | 3 |
1.640 | 2000 | 1 |
1.645 | 10756 | 2 |
Last trade - 11.30am 26/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online